Safety of laser therapy for oral mucositis due to chemotherapy or moleculary targeted drug therapy.
Not Applicable
Completed
- Conditions
- oral mucositis due to chemotherapy or molecularly targeted drug therapy.
- Registration Number
- JPRN-UMIN000028552
- Lead Sponsor
- Osaka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Less than 20 years old, or the case which a oral mucousitis is Grade 4 or 5 by classification of NCI-CTCAE.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in a subjective symptom (VAS), Grade classification of a mouth mucousitis by NCI - CTCAE, the size, a part and contact teeth, the dental hygiene situation and blood exam.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie laser therapy's efficacy in treating oral mucositis from chemotherapy or molecularly targeted drugs?
How does laser therapy compare to standard-of-care treatments like cryotherapy or analgesics for oral mucositis in terms of effectiveness and safety?
Are there specific biomarkers that can predict patient response to laser therapy in chemotherapy-induced oral mucositis?
What are the potential adverse events associated with laser therapy for oral mucositis in cancer patients and how are they managed?
What combination approaches involving laser therapy and other interventions are being explored for managing oral mucositis in oncology?